299 related articles for article (PubMed ID: 29527499)
1. Visual processing deficits in 22q11.2 Deletion Syndrome.
Biria M; Tomescu MI; Custo A; Cantonas LM; Song KW; Schneider M; Murray MM; Eliez S; Michel CM; Rihs TA
Neuroimage Clin; 2018; 17():976-986. PubMed ID: 29527499
[TBL] [Abstract][Full Text] [Related]
2. Altered auditory processing in frontal and left temporal cortex in 22q11.2 deletion syndrome: a group at high genetic risk for schizophrenia.
Rihs TA; Tomescu MI; Britz J; Rochas V; Custo A; Schneider M; Debbané M; Eliez S; Michel CM
Psychiatry Res; 2013 May; 212(2):141-9. PubMed ID: 23137800
[TBL] [Abstract][Full Text] [Related]
3. Early and late stages of visual processing in individuals in prodromal state and first episode schizophrenia: an ERP study.
Oribe N; Hirano Y; Kanba S; del Re EC; Seidman LJ; Mesholam-Gately R; Spencer KM; McCarley RW; Niznikiewicz MA
Schizophr Res; 2013 May; 146(1-3):95-102. PubMed ID: 23433503
[TBL] [Abstract][Full Text] [Related]
4. Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms.
Donnelly NA; Bartsch U; Moulding HA; Eaton C; Marston H; Hall JH; Hall J; Owen MJ; van den Bree MBM; Jones MW
Elife; 2022 Aug; 11():. PubMed ID: 36039635
[TBL] [Abstract][Full Text] [Related]
5. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
[TBL] [Abstract][Full Text] [Related]
6. Altered auditory processing and effective connectivity in 22q11.2 deletion syndrome.
Larsen KM; Mørup M; Birknow MR; Fischer E; Hulme O; Vangkilde A; Schmock H; Baaré WFC; Didriksen M; Olsen L; Werge T; Siebner HR; Garrido MI
Schizophr Res; 2018 Jul; 197():328-336. PubMed ID: 29395612
[TBL] [Abstract][Full Text] [Related]
7. Assessing auditory processing endophenotypes associated with Schizophrenia in individuals with 22q11.2 deletion syndrome.
Francisco AA; Foxe JJ; Horsthuis DJ; DeMaio D; Molholm S
Transl Psychiatry; 2020 Mar; 10(1):85. PubMed ID: 32139692
[TBL] [Abstract][Full Text] [Related]
8. Individuals with 22q11.2 deletion syndrome are impaired at explicit, but not implicit, discrimination of local forms embedded in global structures.
Giersch A; Glaser B; Pasca C; Chabloz M; Debbané M; Eliez S
Am J Intellect Dev Disabil; 2014 May; 119(3):261-75. PubMed ID: 24871794
[TBL] [Abstract][Full Text] [Related]
9. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
10. Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk.
Francisco AA; Horsthuis DJ; Popiel M; Foxe JJ; Molholm S
Neuroimage Clin; 2020; 27():102351. PubMed ID: 32731196
[TBL] [Abstract][Full Text] [Related]
11. Early visual processing and adaptation as markers of disease, not vulnerability: EEG evidence from 22q11.2 deletion syndrome, a population at high risk for schizophrenia.
Francisco AA; Foxe JJ; Horsthuis DJ; Molholm S
Schizophrenia (Heidelb); 2022 Mar; 8(1):28. PubMed ID: 35314711
[TBL] [Abstract][Full Text] [Related]
12. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.
Mekori-Domachevsky E; Guri Y; Yi J; Weisman O; Calkins ME; Tang SX; Gross R; McDonald-McGinn DM; Emanuel BS; Zackai EH; Zalsman G; Weizman A; Gur RC; Gur RE; Gothelf D
Schizophr Res; 2017 Oct; 188():42-49. PubMed ID: 28041919
[TBL] [Abstract][Full Text] [Related]
13. The social brain network in 22q11.2 deletion syndrome: a diffusion tensor imaging study.
Olszewski AK; Kikinis Z; Gonzalez CS; Coman IL; Makris N; Gong X; Rathi Y; Zhu A; Antshel KM; Fremont W; Kubicki MR; Bouix S; Shenton ME; Kates WR
Behav Brain Funct; 2017 Feb; 13(1):4. PubMed ID: 28209179
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils to lymphocytes ratio and psychosis in 22q11.2 deletion syndrome - Clinical and scientific implications.
Mekori-Domachevsky E; Taler M; Weinberger R; Guri Y; Dar S; Shani S; Dekel I; Weizman A; Gothelf D
Schizophr Res; 2021 May; 231():164-169. PubMed ID: 33866261
[TBL] [Abstract][Full Text] [Related]
15. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
[TBL] [Abstract][Full Text] [Related]
16. White matter microstructural abnormalities of the cingulum bundle in youths with 22q11.2 deletion syndrome: associations with medication, neuropsychological function, and prodromal symptoms of psychosis.
Kates WR; Olszewski AK; Gnirke MH; Kikinis Z; Nelson J; Antshel KM; Fremont W; Radoeva PD; Middleton FA; Shenton ME; Coman IL
Schizophr Res; 2015 Jan; 161(1):76-84. PubMed ID: 25066496
[TBL] [Abstract][Full Text] [Related]
17. Cognitive behavioral therapy in 22q11.2 microdeletion with psychotic symptoms: What do we learn from schizophrenia?
Demily C; Franck N
Eur J Med Genet; 2016 Nov; 59(11):596-603. PubMed ID: 27639442
[TBL] [Abstract][Full Text] [Related]
18. Neuroanatomical underpinnings of autism symptomatology in carriers and non-carriers of the 22q11.2 microdeletion.
Gudbrandsen M; Bletsch A; Mann C; Daly E; Murphy CM; Stoencheva V; Blackmore CE; Rogdaki M; Kushan L; Bearden CE; Murphy DGM; Craig MC; Ecker C
Mol Autism; 2020 Jun; 11(1):46. PubMed ID: 32513259
[TBL] [Abstract][Full Text] [Related]
19. Recognition of facial emotion expressions and perceptual processes in 22q11.2 deletion syndrome.
Buzzanca A; Accinni T; Frascarelli M; Troisi E; Kotzalidis GD; Di Bonaventura C; Fanella M; Putotto C; Marino B; Pasquini M; Biondi M; Di Fabio F
Early Interv Psychiatry; 2023 Jan; 17(1):76-84. PubMed ID: 35347860
[TBL] [Abstract][Full Text] [Related]
20. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
Mekori-Domachevsky E; Taler M; Shoenfeld Y; Gurevich M; Sonis P; Weisman O; Weizman A; Gothelf D
J Clin Psychiatry; 2017; 78(9):e1219-e1225. PubMed ID: 29141125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
